Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
- PMID: 2496309
- DOI: 10.1056/NEJM198905043201802
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
Abstract
To evaluate the effect of endotoxin on the fibrinolytic response, we administered Escherichia coli endotoxin (4 ng per kilogram of body weight) intravenously to 19 healthy volunteers and measured fibrinolytic proteins, protease inhibitors, neutrophil elastase, and von Willebrand factor in serial blood samples obtained over 24 hours. One hour after endotoxin administration, the level of tissue plasminogen activator (t-PA) antigen rose from 10 to 23 ng per milliliter, peaking at 52 ng per milliliter at three hours. The level of alpha 2-plasmin inhibitor-plasmin complexes increased sevenfold, peaking at three hours. Plasminogen-activator inhibitor-1 activity rose more slowly, from 7 U per milliliter to a maximum of 49 U per milliliter at five hours. The concentrations of neutrophil elastase and von Willebrand antigen were unchanged at one hour, increased approximately threefold by 3 hours, and remained elevated at 24 hours. None of these measures changed in a control group (n = 5) given intravenous saline instead of endotoxin. We studied t-PA functional activity in four subjects. The level of activity rose rapidly, from 1.2 ng per milliliter at base line to 8.3 ng per milliliter at one hour and 13.9 ng per milliliter at two hours; it was undetectable at three hours. This increase in plasminogen activator activity was abolished in vitro by incubation of t-PA with an antiserum specific for human t-PA, suggesting that t-PA may be directly responsible for plasmin generation in the response to endotoxin. We conclude from this study of healthy subjects that endotoxin activates the fibrinolytic system, beginning with release of t-PA in the blood within one hour. The early activation of plasmin by endotoxin may prevent thrombosis, and the increase in fibrinolysis is then offset by the release of plasminogen activator inhibitor.
Comment in
-
Plasminogen activation and endotoxin.N Engl J Med. 1989 Sep 28;321(13):903-4. doi: 10.1056/NEJM198909283211314. N Engl J Med. 1989. PMID: 2788817 No abstract available.
Similar articles
-
Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.Haematologica. 1999 Apr;84(4):306-11. Haematologica. 1999. PMID: 10190943
-
Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.Arch Intern Med. 1986 Jan;146(1):188-91. Arch Intern Med. 1986. PMID: 2935105
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
-
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.Thromb Haemost. 1988 Dec 22;60(3):361-4. Thromb Haemost. 1988. PMID: 3149043
-
Fibrin-specific thrombolytic agents.Klin Wochenschr. 1988;66 Suppl 12:15-23. Klin Wochenschr. 1988. PMID: 3126344 Review.
Cited by
-
Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases.Int J Clin Lab Res. 1992;21(3):214-20. doi: 10.1007/BF02591649. Int J Clin Lab Res. 1992. PMID: 1591371 Free PMC article. Review.
-
The roles of activated protein C in experimental trauma models.Chin J Traumatol. 2018 Dec;21(6):311-315. doi: 10.1016/j.cjtee.2018.07.005. Epub 2018 Dec 11. Chin J Traumatol. 2018. PMID: 30594428 Free PMC article. Review.
-
Different Effects of Lipopolysaccharide on Plasminogen Activator Inhibitor-1 Production in Aortic Media in Vivo and in Culture.J Thromb Thrombolysis. 1996;3(3):215-223. doi: 10.1007/BF00181664. J Thromb Thrombolysis. 1996. PMID: 10613985
-
Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.Int J Hematol. 2006 Dec;84(5):398-405. doi: 10.1532/IJH97.05190. Int J Hematol. 2006. PMID: 17189219 Clinical Trial.
-
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6998-7002. doi: 10.1073/pnas.89.15.6998. Proc Natl Acad Sci U S A. 1992. PMID: 1495992 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources